Long COVID Subsides in a Majority of Healthcare Workers
January 8th 2025A survey of this population showed that over a 2 and ½ year period, there was a decrease in post-acute sequelae of SARS-CoV-2 infection (PASC). However, 1% of respondents said they are still dealing with restrictions in their lives.
Paxlovid Reduces Short and Long-Term Adverse Outcomes in COVID-19 Patients with Kidney Disease
Published: January 6th 2025 | Updated: January 6th 2025Recent study highlights Paxlovid’s ability to reduce hospitalizations and mortality in high-risk populations, but underscores the need for personalized treatment.